Surgical therapy of oesophageal carcinoma

DOI PDF Web Site 21 Citations
  • J M Müller
    Department of Surgery University of Cologne, Cologne, FRG
  • H Erasmi
    Department of Surgery University of Cologne, Cologne, FRG
  • M Stelzner
    Department of Surgery University of Cologne, Cologne, FRG
  • U Zieren
    Department of Surgery University of Cologne, Cologne, FRG
  • H Pichlmaier
    Department of Surgery University of Cologne, Cologne, FRG

Abstract

<jats:title>Abstract</jats:title> <jats:p>During the past 10 years, postoperative mortality associated with surgical treatment of oesophageal carcinoma has been reduced by one-half. However, it appears that all efforts to improve long-term survival with extensive excisional procedures and adjuvant chemotherapy and radiotherapy have failed. Fifty-six of 100 patients presenting to the surgeon with an oesophageal carcinoma have resectable disease. Recent studies suggest that seven of them will die from postoperative complications and 49 patients will be discharged from the hospital after an average of 3 weeks. Of these patients, 27 will survive the first, 12 the second, and ten the fifth year. Although it may be possible to further reduce postoperative complications and mortality, the chances of improving the long-term prognosis of patients with oesophageal carcinoma seem small.</jats:p>

Journal

Citations (21)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top